Aligned Bio funding news – Sweden-based Aligned Bio Secures €1.6Million in Funding

The company will use the money to improve and scale up its technology for making nanowires. In addition to the funding, Aligned Bio has also been accepted into the SmiLe incubator program, which will help the company grow.

Kenneth Harlow, CEO of Aligned Bio, said, "We believe our DNA analysis technology is nearly ready to attract a partner who can help bring it to market. I’m excited to work with SmiLe’s network and business development expertise, as well as use their labs and equipment to advance our work."

Aligned Bio, led by Kenneth Harlow, is developing a new technology platform using nanowires for biosensors. The company is focusing on two key areas: disease diagnostics (like cancer) and genome sequencing (mapping DNA).

Read also - Oriole Networks funding news – London-based Oriole Networks Secures an Additional €20.2 Million Funding

Their technology can analyze longer DNA fragments and is 10 to 100 times more sensitive in diagnostics than current commercial sensors. It also makes the production of nanowires simpler and more cost-effective than older methods. The company is now increasing production to keep up with demand.

About SmiLe Venture Hub

SmiLe is a venture hub that helps life science startups grow from early ideas to full commercialization. Recently, Ulrika Ringdahl became CEO of SmiLe, replacing Ebba Fåhraeus, who stepped down after 10 years.

SmiLe supports startups through every stage of development, offering tailored programs, educational courses, and access to top-quality lab facilities.

Ulrika Ringdahl, CEO of SmiLe said, “We’re excited that Aligned Bio has secured this funding. It will help their innovative products reach the market faster and benefit patients. We look forward to supporting them on their journey.”

About Aligned Bio

Aligned Bio’s technology for fast and easy DNA detection has the potential to make a big impact on DNA sequencing and biomarker detection.